Affimed Therapeutics' Series E Round

Affimed Therapeutics raised a round of funding on September 02, 2014.

Affimed Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. Affimed's product candidates are being developed in the…

Articles about Affimed Therapeutics' Series E Round: